ArticleCurrent oncology (Toronto, Ont.)2021

Rationale and Design of BeatNF2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Bevacizumab in Patients with Neurofibromatosis Type 2 Related Vestibular Schwannoma.

Masazumi Fujii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.